Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acetazolamide SR for prevention of acute mountain sickness
CTR20231401Phase 3Completed
- Sponsor
- Henan Zhongshuai Pharmaceutical Technology
- Start
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of acetazolamide in acute mountain sickness (AMS), sponsored by Henan Zhongshuai Pharmaceutical Technology. Started May 2023; status: completed.
02
Drugs
acetazolamide
03
Conditions
acute mountain sickness (AMS)
Beyond the preview
Go deeper on CTR20231401.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20231401.